Back to Search Start Over

The End of a Controversy: The Rise, Fall, and Redemption of Paclitaxel-Coated Devices.

Authors :
Secemsky EA
Yeh RW
Schneider PA
Gray W
Parikh S
Source :
The American journal of cardiology [Am J Cardiol] 2024 Apr 01; Vol. 216, pp. 43-45. Date of Electronic Publication: 2024 Feb 17.
Publication Year :
2024

Abstract

Competing Interests: Declaration of Competing Interest Dr. Eric A. Secemsky : consultant to Medtronic, Boston Scientific, Philips, BD, Cook, Concept Medical. Dr. Robert W. Yeh : consultant to Medtronic and Boston Scientific and research grants from Medtronic, Boston Scientific, Philips, BD, and Cook. Dr. Peter A. Schneider : consultant to Medtronic, Boston Scientific, Surmodics, Acotec, Philips. Dr. William Gray : consults for Philips, Medtronic, Boston Scientific, Surmodics, Encompass Vascular, eFemoral, Cagent, Sonovascular, Conformal Medical, Contego Medical, ReValve, Alucent, and Edwards Lifesciences; and holds stock with eFemoral, Encompass Vascular, Xenter, and Reflow Medical. Dr. Sahil Parikh : serves on the advisory boards for Abbott Vascular, Boston Scientific, Cordis, Medtronic, and Philips; and receives institutional research funding from Abbott Vascular, Boston Scientific, Surmodics, TriReme Medical, Shockwave Medical, Reflow Medical, Acotec, and Concept Medical; and consults for Terumo, Inari, Penumbra and Canon. SAP has equity in Advanced Nanotherapies, eFemoral, and Encompass Vascular.

Details

Language :
English
ISSN :
1879-1913
Volume :
216
Database :
MEDLINE
Journal :
The American journal of cardiology
Publication Type :
Editorial & Opinion
Accession number :
38369174
Full Text :
https://doi.org/10.1016/j.amjcard.2024.01.027